NCT00042601View on ClinicalTrials.gov

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

Pramlintide acetate

Pramlintide injection will be supplied in 5-mL multidose glass vials with rubber stoppers.

DRUG

Placebo

placebo injection will be supplied in 5-mL multidose glass vials with a rubber stopper

Trial Locations (1)

5000

Royal Adelaide Hospital, Adelaide

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY